Riferimento:
J Invest Dermatol. 2012 Nov;132(11):2497-9.
Autori:
Gamba CA, Tang JY.
Fonte:
J Invest Dermatol. 2012 Nov;132(11):2497-9.
Anno:
2012
Azione:
Valutare il rischio di carcinoma a cellule basali (BCC) ex-novo con tretinoina topica nella chemioprevenzione per i soldati Veterani.
Target:
Tretinoina/carcinoma a cellule basali.
ABSTRACT
Dyer et al. (this issue) assess the risk of new basal cell carcinoma (BCC) in the Veterans Affairs topical tretinoin chemoprevention trial, which included individuals with a history of at least two prior keratinocyte carcinomas. In addition to known risk factors for a future BCC, such as number of prior BCCs, a history of eczema and lower education levels were also associated with greater risk.
Free full text
Sostanze: